Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex PharmafiledCriticalVertex Pharma
Publication of ECSP034653ApublicationCriticalpatent/ECSP034653A/es
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invención se refiere a compuestos de la formula I o un derivado farmacéuticamente aceptable o prodroga del mismo. Los compuestos son útiles como inhibidores de actividad de girasas bacterianas. La presente invención también se refiere a métodos de tratamiento de infecciones bacterianas en mamíferos. La presente invención también se refiere a métodos por decrecimiento de cantidad bacteriana en una muestra biológica.
EC2003004653A2000-12-152003-06-12Inhibidores de girasa y usos del mismo
ECSP034653A
(es)
2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
Subgrupo de compuestos basados en oxabispidina comprendiendo un grupo alquilo amidasustituido, proceso de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones